TAICH ADAM (Chief Financial Officer) sold 12.8% of their position (46.39K shares) of 10X GENOMICS, INC. on the open market
Open‑market sale worth $3.00M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/11/2026ACC: 0001610717-26-000414
Officer· Chief Financial Officer
Since Feb 2026
-46.39K
Net shares
Net seller
$3.00M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
46.39K disposed
Non-Derivative Transactions3
Class A Common Stock
Direct
Shares
−1.21K
Price / share
$63.68
Trade value
$76.79K
% of position
0.3%
9/9/2026
362.73K→361.53K
Class A Common Stock
Direct
Shares
−31.43K
Price / share
$64.31
Trade value
$2.02M
% of position
8.7%
9/9/2026
361.53K→330.10K
Class A Common Stock
Direct
Shares
−13.75K
Price / share
$65.26
Trade value
$897.55K
% of position
4.2%
9/9/2026
330.10K→316.34K
Total
Net shares
−46.39K
Net value
-$3M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/9/2026 | S · Sale | −1.21K | $63.68 | $76.79K | 0.3% | 362.73K | 361.53K |
| Class A Common Stock Direct | 9/9/2026 | S · Sale | −31.43K | $64.31 | $2.02M | 8.7% | 361.53K | 330.10K |
| Class A Common Stock Direct | 9/9/2026 | S · Sale | −13.75K | $65.26 | $897.55K | 4.2% | 330.10K | 316.34K |
| Total | −46.39K | -$3M | ||||||
Derivative Transactions0
No derivative transactions reported